117 related articles for article (PubMed ID: 9536244)
1. Psoriasis vulgaris treated successfully with mycophenolate mofetil.
Haufs MG; Beissert S; Grabbe S; Schütte B; Luger TA
Br J Dermatol; 1998 Jan; 138(1):179-81. PubMed ID: 9536244
[TBL] [Abstract][Full Text] [Related]
2. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.
Daudén E; Sánchez-Peinado C; Ruiz-Genao D; García-F-Villalta M; Onate MJ; García-Díez A
Br J Dermatol; 2004 Jan; 150(1):132-5. PubMed ID: 14746627
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.
Grundmann-Kollmann M; Mooser G; Schraeder P; Zollner T; Kaskel P; Ochsendorf F; Boehncke WH; Kerscher M; Kaufmann R; Peter RU
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866
[TBL] [Abstract][Full Text] [Related]
4. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.
Kitchin JE; Pomeranz MK; Pak G; Washenik K; Shupack JL
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):445-9. PubMed ID: 9308561
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.
Geilen CC; Arnold M; Orfanos CE
Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019
[TBL] [Abstract][Full Text] [Related]
6. Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis.
Davison SC; Morris-Jones R; Powles AV; Fry L
Br J Dermatol; 2000 Aug; 143(2):405-7. PubMed ID: 10951153
[TBL] [Abstract][Full Text] [Related]
7. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
[TBL] [Abstract][Full Text] [Related]
8. A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.
Beissert S; Pauser S; Sticherling M; Frieling U; Loske KD; Frosch PJ; Haase I; Luger TA
Dermatology; 2009; 219(2):126-32. PubMed ID: 19546522
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial.
Zhou Y; Rosenthal D; Dutz J; Ho V
J Cutan Med Surg; 2003; 7(3):193-7. PubMed ID: 12704533
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
Nousari HC; Sragovich A; Kimyai-Asadi A; Orlinsky D; Anhalt GJ
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil and skin diseases.
Hartmann M; Enk A
Lupus; 2005; 14 Suppl 1():s58-63. PubMed ID: 15803935
[TBL] [Abstract][Full Text] [Related]
12. Enteric-coated mycophenolate sodium: therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patients.
Sollinger H
Transplant Proc; 2004 Mar; 36(2 Suppl):517S-520S. PubMed ID: 15041399
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
Grundmann-Kollmann M; Korting HC; Behrens S; Kaskel P; Leiter U; Krähn G; Kerscher M; Peter RU
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927
[TBL] [Abstract][Full Text] [Related]
14. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
15. [Use of mycophenolate mofetil in kidney transplantation].
Hrvacevic R; Ignjatovic Lj; Vavic N
Vojnosanit Pregl; 2001; 58(4):415-9. PubMed ID: 11712223
[TBL] [Abstract][Full Text] [Related]
16. Severe generalized pustular psoriasis treated with mycophenolate mofetil.
Ji YZ; Geng L; Ma XH; Wu Y; Zhou HB; Li B; Xiao T; Chen HD
J Dermatol; 2011 Jun; 38(6):603-5. PubMed ID: 21352286
[No Abstract] [Full Text] [Related]
17. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment.
Hutchinson P; Jose M; Atkins RC; Holdsworth SR
Transpl Immunol; 2004; 13(1):55-61. PubMed ID: 15203129
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
Akhyani M; Chams-Davatchi C; Hemami MR; Fateh S
J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil.
Zwerner J; Fiorentino D
Dermatol Ther; 2007; 20(4):229-38. PubMed ID: 17970888
[TBL] [Abstract][Full Text] [Related]
20. The use of Mycophenolate Mofetil (Cellcept) in renal transplantation.
Vanrenterghem Y
Nephron; 1997; 76(4):392-9. PubMed ID: 9274835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]